Nutritional alterations are common in HIV infection. Early studies document
ed weight loss and protein depletion, a finding associated with body cell m
ass depletion in untreated patients. The application of highly active antir
etroviral therapy has led to a decreased incidence of malnutrition, althoug
h altered body fat distribution and metabolic alterations, including hyperl
ipidemia and insulin resistance, are common sequelae. The development of ma
lnutrition is multifactorial and occurs through changes in caloric intake,
nutrient absorption, or energy expenditure. Clinically, malnutrition develo
ps as a result of either starvation or cachexia. Other hormonal and endocri
nologic alterations include hypercortisolemia and hypogonadism. The rationa
le for providing nutritional support to AIDS patients is based upon the ass
umptions that nutrition status can be improved and that such improvements h
ave clinical benefits. The results or hypercaloric feeding studies, includi
ng the use of appetite stimulants, indicate that weight gain is possible bu
t that the weight gained is predominantly fat. In contrast, anabolic agents
and resistance training exercise have been shown to promote body cell mass
repletion and skeletal muscle gain. Cytokine inhibitors also have been eva
luated for the treatment of wasting in HIV infection. Development of combin
ation therapies, preventive therapies, and efficient and cost-effective the
rapies are current tasks in the field.